NANNI, JACOPO
 Distribuzione geografica
Continente #
NA - Nord America 207
EU - Europa 137
AS - Asia 52
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 400
Nazione #
US - Stati Uniti d'America 199
IT - Italia 42
FR - Francia 21
DE - Germania 18
IE - Irlanda 15
CN - Cina 11
BG - Bulgaria 10
IN - India 7
JP - Giappone 7
ES - Italia 6
GB - Regno Unito 6
NL - Olanda 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
KR - Corea 5
MX - Messico 5
CH - Svizzera 4
FI - Finlandia 4
TH - Thailandia 4
BE - Belgio 2
CA - Canada 2
TR - Turchia 2
AU - Australia 1
BZ - Belize 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IL - Israele 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SG - Singapore 1
UG - Uganda 1
VN - Vietnam 1
Totale 400
Città #
Columbus 31
Ashburn 26
Dublin 15
Fairfield 13
Sofia 10
Seattle 8
Chicago 7
Mountain View 7
Cambridge 6
Santa Cruz 6
Amsterdam 5
Boardman 5
Bologna 5
Cuauhtemoc 5
Forlì 5
Milan 5
Qom 5
Bangkok 4
Barcelona 4
Bremen 4
Dallas 4
Helsinki 4
Houston 4
New York 4
Waltham 4
Woodbridge 4
Atlanta 3
Boston 3
Buffalo 3
El Cerrito 3
Las Vegas 3
Los Angeles 3
Paris 3
Tokyo 3
Wilmington 3
Ankara 2
Ann Arbor 2
Beijing 2
Bengaluru 2
Frankfurt am Main 2
Gangnam-gu 2
Geel 2
Genoa 2
Hangzhou 2
Hyderabad 2
Munich 2
Redmond 2
Reggio Emilia 2
Rome 2
Shanghai 2
Southend 2
Auckland 1
Bagnacavallo 1
Bari 1
Bassano del Grappa 1
Bern 1
Bogotá 1
Bollate 1
Brockport 1
Bryn Mawr 1
Carlsbad 1
Carmel 1
Changwon 1
Como 1
Coraopolis 1
Crema 1
Dearborn 1
Decatur 1
Denver 1
Dong-gu 1
Düsseldorf 1
Essen 1
Flawil 1
Frankfurt Am Main 1
Greenwood 1
Grenoble 1
Groningen 1
Gurugram 1
Göppingen 1
Henderson 1
Hong Kong 1
Ichibancho 1
Las Palmas de Gran Canaria 1
Lebanon 1
Lossiemouth 1
Lugo 1
Malvern 1
Melzo 1
Memphis 1
Minusio 1
Montreal 1
Musile di Piave 1
Nagasaki 1
New Delhi 1
Okazaki 1
Osaka 1
Oslo 1
Ottawa 1
Perth 1
Petah Tikva 1
Totale 308
Nome #
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia, file e1dcb332-f750-7715-e053-1705fe0a6cc9 111
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file e1dcb338-c510-7715-e053-1705fe0a6cc9 99
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters, file e1dcb339-2ea1-7715-e053-1705fe0a6cc9 54
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia, file 9ef9584e-e1bf-477a-a649-7344cfbae617 46
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, file e1dcb338-75ea-7715-e053-1705fe0a6cc9 34
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents, file d74327b8-400c-4f10-9f39-c15714745631 20
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia, file e1dcb337-384e-7715-e053-1705fe0a6cc9 14
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant, file e1dcb339-3ad2-7715-e053-1705fe0a6cc9 10
Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a, file e1dcb339-4cde-7715-e053-1705fe0a6cc9 8
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure, file 3905c69c-0fe8-4ca6-8965-d1d87a0ed15f 4
Pharmacological inhibition of wip1 sensitizes acute myeloid leukemia cells to the mdm2 inhibitor nutlin-3a, file d1924f4b-4a2b-4152-88b8-e0fbf4f2d037 4
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file 6b91808a-89ec-451f-bcac-4bd100943c74 3
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study, file b387d513-c986-410c-810c-62ca0510fad6 3
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia, file c03661a0-6d59-43e7-8bfd-9f7376be3098 1
Editorial: Precision medicine for acute myeloid leukemia, file d5ff50e4-c060-42f0-8bb2-063167b43b75 1
Totale 412
Categoria #
all - tutte 1.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 3 4 6 6 4 6 2 3 2
2020/202123 2 1 3 1 5 4 2 1 1 2 1 0
2021/202231 1 0 0 3 3 0 0 2 0 3 15 4
2022/2023134 2 4 11 14 12 14 10 11 19 11 17 9
2023/2024188 4 9 4 23 13 32 13 15 18 19 38 0
Totale 412